Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02046382 · ClinicalTrials.gov registry record · Phase 4
RCT (Randomized Controlled Trial) of IV Acetaminophen for Post Cesarean Pain Relief
A Phase 4 study, sponsored by TriHealth.
- Completed
- Registry status
- Phase 4
- Development phase
- 132
- Enrollment target
NCT02046382: Completed Phase 4 study, sponsored by TriHealth.
NCT02046382 is a Phase 4 study that has completed, run by TriHealth. The registered enrollment target is 132 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (75% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02046382, a Phase 4 study, has completed, sponsored by TriHealth.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 132 participants
- Enrollment target
Study Summary
This study is being done to evaluate the scheduled use of intravenous (IV) acetaminophen among cesarean section patients. The study hopes to find out if patients who receive scheduled IV acetaminophen for 48 hours following delivery have lower self-reported pain scores and use less narcotic pain medication than patients who do not receive IV acetaminophen.
Primary Outcome
Total oxycodone (mg) for breakthrough pain during inpatient stay
Interventions
- DRUG Placebo
- DRUG IV Acetaminophen
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 132 participants |
| Start Date | 2014-01 |
| Est. Completion | 2017-05 |
| Phase | Phase 4 |
What the finished NCT02046382 record still lists
NCT02046382 is an interventional study that assigns participants to a tested intervention. The registered 132 participants enrollment target is mid-sized for trials with a published cap, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (75% lower).
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT02046382 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02046382 about?
NCT02046382 is a clinical study titled "RCT (Randomized Controlled Trial) of IV Acetaminophen for Post Cesarean Pain Relief". This study is being done to evaluate the scheduled use of intravenous (IV) acetaminophen among cesarean section patients. The study hopes to find out if patients who receive scheduled IV acetaminophen for 48 hours following delivery have lower self-reported pain scores and use less narcotic pain med...
What is the current status of trial NCT02046382?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 132 participants. The study started on 2014-01. Estimated completion is 2017-05.
What interventions are being tested in trial NCT02046382?
The interventions under investigation include: Placebo (DRUG), IV Acetaminophen (DRUG).
Who is sponsoring clinical trial NCT02046382?
This trial is sponsored by TriHealth, which has 81 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02046382's enrollment target sits among peer trials
132 610th of 2000 higher than 1,382 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01766297 · 132 participants · Phase 2
Phase II Protocol of Proton Therapy for Partial Breast Irradiation in Early Stage Breast Cancer
- NCT04002947 · 132 participants · Phase 2
Acalabrutinib With DA-EPOCH-R or R-CHOP for People With Untreated Diffuse Large B-cell Lymphoma
- NCT04128189 · 132 participants · Phase 3
Shingrix in Renal Transplant Recipients
- NCT04199780 · 132 participants · NA
Effects of tDCS Combined With CBI on Postsurgical Pain
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia